Genmab A/S
GMAB
$19.91
-$0.34-1.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 194.55% | -8.17% | 5.30% | 90.10% | -66.97% |
| Total Depreciation and Amortization | -0.42% | -30.26% | 638.72% | -61.74% | -32.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -207.27% | 91.12% | 346.76% | -130.60% | 1,854.09% |
| Change in Net Operating Assets | 110.36% | 22.33% | -262.95% | 448.84% | 172.49% |
| Cash from Operations | 29.38% | 37.23% | -0.90% | -8.73% | -18.86% |
| Capital Expenditure | -139.91% | -43.73% | 4.44% | 57.85% | 32.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.85% | -92.36% | 345.53% | -280.04% | -133.52% |
| Cash from Investing | -64.50% | 102.61% | -503.24% | -228.82% | -143.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 10.53% | 20.83% | 4.00% | -56.25% |
| Issuance of Common Stock | -74.42% | 168.75% | -72.88% | 555.56% | -77.50% |
| Repurchase of Common Stock | 97.35% | 90.09% | -383.81% | -10,400.00% | -50.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.05% | 90.76% | -408.14% | -2,627.81% | -208.74% |
| Foreign Exchange rate Adjustments | 2,224.41% | 205.65% | -108.82% | 153.55% | -281.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.57% | 119.86% | -5,100.80% | -133.45% | -82.72% |
